CAS: 461054-93-3 - (3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester
Fórmula:C26H35N3O5
InChI:InChI=1/C26H35N3O5/c1-14(2)11-20-23-17(16-8-7-15(33-6)12-19(16)27-23)13-21-24(31)28-18(25(32)29(20)21)9-10-22(30)34-26(3,4)5/h7-8,12,14,18,20-21,27H,9-11,13H2,1-6H3,(H,28,31)/t18-,20-,21-/m0/s1
- Sinónimos:
- Pyrazino[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid, 1,2,3,4,6,7,12,12a-octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxo-, 1,1-dimethylethyl ester, (3S,6S,12aS)-
- tert-Butyl 3-[(3S,6S,12aS)-6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl]propanoate
- tert-butyl 3-[(3S,6S,12aS)-9-methoxy-6-(2-methylpropyl)-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl]propanoate
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Ko143 hydrate REF: 7W-GL0099CAS: 461054-93-3 | ≥ 98.0% | A consultar | Vie 29 Nov 24 | |
Ko 143 REF: TM-TQ0186CAS: 461054-93-3 | 99.89% | 46,00 €~679,00 € | Jue 05 Dic 24 | |
KO 143 REF: TR-K655000CAS: 461054-93-3 | - - - | 15.234,00 € | Mié 08 Ene 25 | |
KO 143 REF: 3D-LTA05493CAS: 461054-93-3 | Min. 95% | A consultar | Jue 09 Ene 25 |
Ko143 hydrate
CAS:461054-93-3
Fórmula:
C26H35N3O5·xH2O
Pureza:
≥ 98.0%
Forma y color:
White to off-white powder
Peso molecular:
469.57 (anhydrous)
Ref: 7W-GL0099
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 29 de Noviembre de 2024
Ko 143
CAS:461054-93-3
Ko 143 is a selective inhibitor of ATP-binding cassette sub-family G member 2 (ABCG2; BCRP).
Fórmula:
C26H35N3O5
Pureza:
99.89%
Forma y color:
Solid
Peso molecular:
469.57
Ref: TM-TQ0186
2mg | 46,00 € | ||
5mg | 69,00 € | ||
10mg | 109,00 € | ||
25mg | 208,00 € | ||
50mg | 377,00 € | ||
100mg | 679,00 € | ||
1mL*10mM (DMSO) | 72,00 € |
Entrega estimada en Estados Unidos, el Jueves 5 de Diciembre de 2024
KO 143
CAS:461054-93-3
KO 143 is a methyltransferase inhibitor that blocks the activity of p-glycoprotein. It has been …
Fórmula:
C26H35N3O5
Pureza:
Min. 95%
Peso molecular:
469.57 g/mol
Ref: 3D-LTA05493
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 9 de Enero de 2025